Thiazolidine-2,4-dione derivatives are promising leads for antileishmanial drug design.
Thiazolidinone ring mimics NADPH binding, thus acting as a noncompetitive inhibitor.
Molecular dynamics support thiazolidine-2,4-dione one binding profile to LmPTR1.